Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP432501.RA1CWyIM5mzlbctimTVknnvTPsRpvGWDINx6pCCEDMma4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP432501.RA1CWyIM5mzlbctimTVknnvTPsRpvGWDINx6pCCEDMma4130_assertion type Assertion NP432501.RA1CWyIM5mzlbctimTVknnvTPsRpvGWDINx6pCCEDMma4130_head.
- NP432501.RA1CWyIM5mzlbctimTVknnvTPsRpvGWDINx6pCCEDMma4130_assertion description "[The evidence for this assertion is strongest in Parkinson's disease (PD), where genetic variability in alpha-synuclein expression affects risk of developing disease, although the oldest evidence for the notion that increased expression of normal sequence protein can lead to disease comes from the observation of Alzheimer's disease in trisomy 21 cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP432501.RA1CWyIM5mzlbctimTVknnvTPsRpvGWDINx6pCCEDMma4130_provenance.
- NP432501.RA1CWyIM5mzlbctimTVknnvTPsRpvGWDINx6pCCEDMma4130_assertion evidence source_evidence_literature NP432501.RA1CWyIM5mzlbctimTVknnvTPsRpvGWDINx6pCCEDMma4130_provenance.
- NP432501.RA1CWyIM5mzlbctimTVknnvTPsRpvGWDINx6pCCEDMma4130_assertion SIO_000772 14976159 NP432501.RA1CWyIM5mzlbctimTVknnvTPsRpvGWDINx6pCCEDMma4130_provenance.
- NP432501.RA1CWyIM5mzlbctimTVknnvTPsRpvGWDINx6pCCEDMma4130_assertion wasDerivedFrom befree-2016 NP432501.RA1CWyIM5mzlbctimTVknnvTPsRpvGWDINx6pCCEDMma4130_provenance.
- NP432501.RA1CWyIM5mzlbctimTVknnvTPsRpvGWDINx6pCCEDMma4130_assertion wasGeneratedBy ECO_0000203 NP432501.RA1CWyIM5mzlbctimTVknnvTPsRpvGWDINx6pCCEDMma4130_provenance.